Towards development of biobetter: L-asparaginase a case study RK Tripathy, J Anakha, AH Pande Biochimica et Biophysica Acta (BBA)-General Subjects 1868 (1), 130499, 2024 | 7 | 2024 |
Human arginase 1, a Jack of all trades? J Anakha, PS Kawathe, S Datta, SS Jawalekar, UC Banerjee, AH Pande 3 Biotech 12 (10), 264, 2022 | 7 | 2022 |
Treating liver cancer through arginine depletion YR Prasad, J Anakha, AH Pande Drug Discovery Today 29 (4), 103940, 2024 | 6 | 2024 |
Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status J Anakha, P Dobariya, SS Sharma, AH Pande Medical Oncology 41 (1), 24, 2023 | 3 | 2023 |
Human arginase I: a potential broad-spectrum anti-cancer agent J Anakha, YR Prasad, N Sharma, AH Pande 3 Biotech 13 (5), 159, 2023 | 3 | 2023 |
Development and characterization of fused human arginase I for cancer therapy SS Jawalekar, PS Kawathe, N Sharma, J Anakha, K Tikoo, AH Pande Investigational New Drugs 41 (5), 652-663, 2023 | 2 | 2023 |
Broad-spectrum anti-cancer activity of fused human arginase variants YR Prasad, J Anakha, SS Jawalekar, AH Pande Investigational New Drugs, 1-7, 2024 | | 2024 |